This energy deficit, while promoting weight loss, can result in fatigue, lightheadedness, and generalized weakness, particularly during the initial weeks of treatment or after dose escalation
I did not realize how many decisions come after weight loss
These drugs are sometimes called dual agonists or doubles. Vikings VK2735 is a double that targets GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, as are Mounjaro and Zepbound
Gastrointestinal losses can result in hypokalaemia, which may manifest as muscle weakness, cramps, cardiac arrhythmias, and constipation
P is for protein in your nutrition, and then S is for strength training
#Pharma #Diabetes #NovoNordisk #Insulin #HealthcareInnovation #CompetitiveIntelligence #GLP1 #Biotech To view or add a comment, sign in A significant development in obesity treatment has emerged from new clinical research